Gail Garland, OBIO CEO talks with BNN about Canada's health science industry

Written By Guest User

Gail Garland, OBIO CEO talks with BNN about the economic and health benefits that accrue to Canada by building a globally competitive Canadian health science industry. Click here for the full interview.

Guest User
Previous

OBIO Strategic Review: December 2015
Next

OBIO Globe & Mail Op-Ed: Canada needs a strategy to reach its biotech potential